Molecular Pathways: CBL Proteins in Tumorigenesis and Antitumor Immunity--Opportunities for Cancer Treatment

Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-13-2490
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Molecular Pathways: The eIF4F Translation Initiation Complex—New Opportunities for Cancer Treatment

Clinical Cancer Research
Cancer ResearchOncology
2016English

Novel Cancer Immunotherapies and Antitumor Immunity

Journal of Immunology Research
MedicineAllergyImmunology
2019English

Molecular Pathways: Targeting P21-Activated Kinase 1 Signaling in Cancer--Opportunities, Challenges, and Limitations

Clinical Cancer Research
Cancer ResearchOncology
2012English

CXCR2 Antibodies for Antitumor Immunity

Science-Business eXchange
2014English

Catechins and Antitumor Immunity

OncoImmunology
OncologyAllergyImmunology
2013English

Reprogramming Antitumor Immunity

Trends in Immunology
AllergyImmunology
2014English

Cyclin D1, Cancer Progression, and Opportunities in Cancer Treatment

Journal of Molecular Medicine
Molecular MedicineDrug DiscoveryGenetics
2016English

Antitumor Immunity as Determining Factor for Prevention of Post-Surgery Cancer Recurrence

Journal of Clinical & Experimental Immunology
2020English

Molecular Pathways and Therapeutic Targets in Lung Cancer

Oncotarget
Oncology
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy